Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment
نویسندگان
چکیده
منابع مشابه
Successful treatment of progressive diffuse PEComatosis.
Amplified fragment length polymorphism analysis of human clinical isolates of Mycobacterium haemophilum from different continents. Clin Microbiol Infect 2009; 15: 924–930. 4 Cangelosi GA, Freeman RJ, Lewis KN, et al. Evaluation of a highthroughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol 2...
متن کاملMeningioangiomatosis: a rare presentation with progressive cortical blindness.
A 58-year-old man presented with a 6-month history of headaches, progressive left homonymous hemianopia, and right-sided paresthesias. MRI revealed bilateral parietal and occipital enhancing lesions (figure 1, A–C) suggestive of cerebritis or posterior reversible encephalopathy syndrome due to history of hypertension. Worsening vision prompted neuroimaging 18 months later, showing contrast-enha...
متن کاملFamilial diffuse progressive encephalopathy.
The purpose of this paper is to present the clinical and neuropathological findings in two idiot brothers in whom the mode and time of onset and the pattern of brain anomalies were remarkably similar. Clinically there were similarities with well-known syndromes such as Tay Sachs and Schilder's disease. However, the ultimate diagnosis was to emphasize the frequent difficulties encountered in det...
متن کاملMulticystic meningioangiomatosis
BACKGROUND Meningioangiomatosis (MA) is a rare hamartomatous lesion. Only six cases of cystic MA have been reported in the literature. CASE PRESENTATION We present a case of multicystic MA. A 21-year-old woman without any stigmata of neurofibromatosis type 2 presented with intractable seizures since 10 years. Brain magnetic resonance imaging revealed a well-defined, multicystic mass with hete...
متن کاملProgressive multifocal leukoencephalopathy: clinical and MR response to treatment.
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease that occurs in immunocompromised hosts. We describe two patients with biopsy-proved PML who showed improvement clinically and radiologically after medical therapy. These cases reveal that interval improvement can in rare instances be consistent with a diagnosis of PML.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology
سال: 2016
ISSN: 0028-3878,1526-632X
DOI: 10.1212/wnl.0000000000002610